Home/XLV

XLV

Health Care Select Sector SPDR Fund

1Y Return
+8.2%
Expense Ratio
0.09%
Dividend Yield
1.55%
AUM
$38.2B
Basic Info
IssuerState Street
CategoryHealthcare
Inception Date1998-12-16

Tracks U.S. healthcare sector companies including pharma and biotech.

Returns & Risk
1Y Return+8.2%
3Y (Ann.)+6.5%
5Y (Ann.)+9.8%
Volatility15.8%
Sharpe Ratio0.65
Max Drawdown-18.5%
Top 10 Holdings
Eli Lilly
12.5%
UnitedHealth
9.8%
Johnson & Johnson
8.2%
Merck
5.5%
AbbVie
5.2%
Pfizer
3.8%
Thermo Fisher
3.5%
Abbott Labs
3.2%
Amgen
2.8%
Danaher
2.5%
Sector Allocation
Pharmaceuticals
32.5%
Biotechnology
22.8%
Medical Devices
18.5%
Managed Care
15.2%
Healthcare Distribution
5.5%
CRO
3.2%
Others
2.3%
Historical Annual Returns
Annual returns over the past 6 years
24%-3%
+13.5%
2020
+24.2%
2021
-2.5%
2022
+2.8%
2023
+8.5%
2024
+4.2%
2025
AI Analysis

XLV is a 医疗型 ETF managed by State Street. Its expense ratio is 0.09%. Fund description: 跟踪美国医疗行业公司，包括制药和生物科技。

Comparison context

For XLV, review the expense ratio, historical returns, dividend yield, concentration, and risk metrics. This is educational research, not personalized investment advice.

Risk Warning

Historical results for XLV can change as markets and fund holdings change. Volatility, maximum drawdown, and past returns do not predict future performance. Verify figures against the issuer's latest prospectus and fact sheet.

Research framework by Magic, an independent analyst with six years of stock and financial-market research experience. Author profile

Data note: Metrics come from third-party market data and ETFSift calculations and may be delayed or change. Verify figures against the fund issuer's latest prospectus and fact sheet.

View methodology and data sources